From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs (Q28236984)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24678061%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Hamilton Morris

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24678061%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

language of work or name

English

0 references

publication date

2014

1 reference

Drug Testing and Analysis

PubMed

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24678061%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24678061%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

issue

7-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24678061%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

page(s)

614-632

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24678061%20AND%20SRC:MED&resulttype=core&format=json

The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate

12 June 2020

cites work

1 reference

Phencyclidine-induced discriminative stimulus is mediated via phencyclidine binding sites on the N-methyl-D-aspartate receptor-ion channel complex, not via sigma(1) receptors

21 January 2018

1 reference

Dose escalation study of the NMDA glycine-site antagonist licostinel in acute ischemic stroke

21 January 2018

1 reference

The ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor

21 January 2018

1 reference

Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis

21 January 2018

1 reference

High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens

21 January 2018

1 reference

History and pharmacology of PCP and PCP-related analogs.

21 January 2018

1 reference

Salvinorin A fails to substitute for the discriminative stimulus effects of LSD or ketamine in Sprague-Dawley rats

21 January 2018

1 reference

Discriminative stimulus effects of narcotics: evidence for multiple receptor-mediated actions

21 January 2018

1 reference

A critical review of pentazocine abuse

21 January 2018

1 reference

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis.

21 January 2018

1 reference

Psychometric evaluation of the altered states of consciousness rating scale (OAV)

21 January 2018

1 reference

Chemical dissociation of human awareness: focus on non-competitive NMDA receptor antagonists

21 January 2018

1 reference

PHARMACOLOGIC EFFECTS OF CI-581, A NEW DISSOCIATIVE ANESTHETIC, IN MAN.

21 January 2018

1 reference

The dusting of America: the image of phencyclidine (PCP) in the popular media.

21 January 2018

1 reference

Structure-activity relationships of the cycloalkyl ring of phencyclidine

21 January 2018

1 reference

Synthesis and anticonvulsant activity of 1-phenylcyclohexylamine analogues

21 January 2018

1 reference

PCP: a review of synthetic methods for forensic clandestine investigation

21 January 2018

1 reference

PCP (Phencyclidine): An Update

21 January 2018

1 reference

New designer drugs N-(1-phenylcyclohexyl)-2-ethoxyethanamine (PCEEA) and N-(1-phenylcyclohexyl)-2-methoxyethanamine (PCMEA): Studies on their metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques

21 January 2018

1 reference

Identification of a new phencyclidine analog, 1-(1-phenylcyclohexyl)-4-methylpiperidine, as a drug of abuse

21 January 2018

1 reference

1-Phenycycloalkylamine derivatives. II. Synthesis and pharmacological activity.

21 January 2018

1 reference

Discriminative stimulus properties of phencyclidine and five analogues in the squirrel monkey.

21 January 2018

1 reference

Determination of 1-(1-Phenylcyclohexyl) Pyrrolidine (PHP) in Postmortem Specimens: A Case Report

21 January 2018

1 reference

A case of phenylcyclohexylpyrrolidine (PHP) intoxication treated with physostigmine

21 January 2018

1 reference

Treatment of phenylcyclohexylpyrrolidine (PHP) psychosis with haloperidol

21 January 2018

1 reference

A fatality due to injection of tiletamine and zolazepam.

21 January 2018

1 reference

Movement disorder caused by abuse of veterinary anesthesia containing tiletamine

21 January 2018

1 reference

Differential effects of dextrorphan and levorphanol on the excitation of rat spinal neurons by amino acids.

21 January 2018

1 reference

Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan

21 January 2018

1 reference

Drugs of Abuse in the Future

21 January 2018

1 reference

Monitoring trends in dextromethorphan abuse using the National Poison Data System: 2000-2010.

21 January 2018

1 reference

Clinical experience with excitatory amino acid antagonist drugs

21 January 2018

1 reference

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

21 January 2018

1 reference

A multiple drug fatality involving MK-801 (dizocilpine), a mimic of phencyclidine

21 January 2018

1 reference

Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs

21 January 2018

1 reference

Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex

21 January 2018

1 reference

Serotonergic agents that activate 5HT2A receptors prevent NMDA antagonist neurotoxicity

21 January 2018

1 reference

Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data

21 January 2018

1 reference

A systematic review of off-label uses of memantine for psychiatric disorders

21 January 2018

1 reference

THE SYNTHESIS OF PHENCYCLIDINE AND OTHER 1-ARYLCYCLOHEXYLAMINES.

21 January 2018

1 reference

Biochemical properties of the brain phencyclidine receptor

21 January 2018

1 reference

Chemical synthesis and molecular pharmacology of hydroxylated 1-(1-phenylcyclohexyl)piperidine derivatives

21 January 2018

1 reference

From "Special K" to "Special M": the evolution of the recreational use of ketamine and methoxetamine

21 January 2018

1 reference

Ketamine-derived designer drug methoxetamine: metabolism including isoenzyme kinetics and toxicological detectability using GC-MS and LC-(HR-)MSn

21 January 2018

1 reference

From the street to the laboratory: analytical profiles of methoxetamine, 3-methoxyeticyclidine and 3-methoxyphencyclidine and their determination in three biological matrices.

21 January 2018

1 reference

Methoxetamine: a novel ketamine analog and growing health-care concern

21 January 2018

1 reference

Novel drugs--novel branding

21 January 2018

1 reference

Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine.

21 January 2018

1 reference

Methoxetamine associated reversible cerebellar toxicity: three cases with analytical confirmation

21 January 2018

1 reference

Ketamine-like effects after recreational use of methoxetamine.

21 January 2018

1 reference

NMDA receptor affinities of 1,2-diphenylethylamine and 1-(1,2-diphenylethyl)piperidine enantiomers and of related compounds

21 January 2018

1 reference

List of drugs in development for neurodegenerative diseases. Update June 2004.

21 January 2018

1 reference

Guidelines and methodological reviews concerning drug abuse liability assessment

21 January 2018

1 reference

Assessing abuse liability during drug development: changing standards and expectations.

21 January 2018

1 reference

Adolescent abuse of dextromethorphan

21 January 2018

1 reference

21 January 2018

1 reference

Abuse of telazol: an animal tranquilizer

21 January 2018

1 reference

Abuse liability assessment of neuroprotectants

21 January 2018

1 reference

Methoxetamine: from drug of abuse to rapid-acting antidepressant

21 January 2018

1 reference

Is methoxydine a new rapid acting antidepressant for the treatment of depression in alcoholics?

21 January 2018

1 reference

Illicit synthesis of phencyclidine (PCP) and several of its analogs

21 January 2018

1 reference

Gacyclidine: a new neuroprotective agent acting at the N-methyl-D-aspartate receptor

21 January 2018

1 reference

The 1977 Street Drug Analysis results: PharmChem Research Foundation

21 January 2018

1 reference

7 January 2021

Phencyclidine: patterns seen in street drug analysis

1 reference

7 January 2021

Phencyclidine: Detection and measurement of toxic precursors and analogs in lllicit samples

1 reference

7 January 2021

Identification of a street drug as N-ethyl-1-phenylcyclohexylamine, a phencyclidine analog

1 reference

7 January 2021

Safety, tolerability, and pharmacokinetics of the N-methyl-D-aspartate antagonist dextrorphan in patients with acute stroke. Dextrorphan Study Group

1 reference

7 January 2021

Fatal intoxication by dextromethorphan: A report on two cases

1 reference

7 January 2021

"DXM": a new drug of abuse?

1 reference

7 January 2021

Identifiers

DOI

10.1002/DTA.1620

2 references

Consolidated OpenCitations Corpus – April 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24678061%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

1 reference

Consolidated OpenCitations Corpus – April 2017

2 references

Consolidated OpenCitations Corpus – April 2017